glp-1 agonist and dpp-4 inhibitor receptor agonists or inhibitors: How to guide the clinician? GLP-1 Receptor Agonists Have better
Description
Integrating behavioral support to enhance adherence
Heart Lung

GLP-1 medications carry serious gastroparesis risks that extend far beyond commonly reported nausea and vomiting, requiring heightened clinical awareness and proactive management strategies

Front Immunol

These changes in food intake were paralleled by amelioration of elevated body weight gain (Figs
Grieco M, Giorgi A, Gentile MC, dErme M, Morano S, Maras B, et al
